Cardiovascular Surgery Pipeline Technology and Market Forecasts To 2015

Published by: GlobalData

Published: Feb. 28, 2009 - 41 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Cardiovascular Surgery Pipeline Technology and Market Forecasts To 2015

2.1 Introduction and Definitions

2.2 Cardiovascular Surgery

2.2.1 Beating Heart Systems

2.2.2 Cardiac Ablation Devices

2.2.3 Cardiopulmonary Bypass Equipment

2.2.4 Perfusion Disposables

2.2.4.1 Oxygenators

2.2.4.2 Custom Packs

2.3 Executive Summary

3 Cardiovascular Surgery Technology Landscape

3.1 Beating Heart Surgery Systems

3.1.1 Beating Heart Surgery Timeline

3.1.2 Beating Heart Surgery Procedure

3.1.3 Beating Heart Surgery Clinical Trials

3.1.4 Beating Heart Surgery Advantage

3.2 Cardiac Ablation Devices

3.2.1 Cardiac Ablation Timeline

3.2.2 Cardiac Ablation Procedure

3.2.3 Cardiac Ablation Clinical Trials

3.2.4 Cardiac Ablation Scores High

4 Cardiovascular Surgery Market

4.1 Overview

4.2 Cardiovascular Surgery Market Size Analysis

4.3 Cardiovascular Surgery Cross Segment Analysis

4.4 Cardiovascular Surgery Market: Trend Analysis

4.4.1 Cardiovascular Surgery Market Drivers

4.4.2 Cardiovascular Surgery Market Restraints

4.5 Cardiovascular Surgery Competitive Landscape

5 Cardiovascular Surgery Products In Pipeline

5.1 PEARL 8.0

5.1.1 Peral 8.0 Product Status

5.1.2 Peral 8.0 Product Description

5.2 Bard Pulsed RF Ablation System

5.2.1 Bard Pulsed RF Ablation System Product Status

5.2.2 Bard Pulsed RF Ablation System Product Description

5.2.3 Bard Pulsed RF Ablation System Clinical Trial

5.3 Periocardiocentesis Tray

5.3.1 Periocardiocentesis Tray Product Status

5.3.2 Product Description

5.4 GTU X-GRAFT

5.4.1 GTU X- GRAFT Product Status

5.4.2 GTU X- GRAFT Product Description

5.5 GTU X2-GRAFT

5.5.1 GTU X2 - GRAFT Product Status

5.5.2 GTU X2 - GRAFT Product Description

5.6 High Intensity Focused Ultra Sound Ablation System

5.6.1 High Intensity Focused Ultra Sound Ablation System Product Status

5.6.2 High Intensity Focused Ultra Sound Ablation System Product Description

5.6.3 High Intensity Focused Ultra Sound Ablation System Clinical Trial 1

5.6.4 High Intensity Focused Ultra Sound Ablation System Clinical Trial 2

5.7 HIFU (High Intensity Focused Ultrasound) Cardiac Ablation system

5.7.1 HIFU (High Intensity Focused Ultrasound) Cardiac Ablation system Product Status

5.7.2 HIFU (High Intensity Focused Ultrasound) Cardiac Ablation system Product Description

5.8 Repel-CV(Child)

5.8.1 Repel - CV (Child) Product Status

5.8.2 Repel - CV (Child) Product Description

5.8.3 Repel - CV(Child) Clinical Trial 1

5.8.4 Repel-CV(Child) Clinical Trial 2

5.9 Non - Invasive Radiosurgical System

5.9.1 Non - invasive Radiosurgical System Product Status

5.9.2 Non - Invasive Radiosurgical System Product Description

5.10 SOLAR Surgical Ablation System

5.10.1 SOLAR Surgical Ablation System Product Status

5.10.2 SOLAR Surgical Ablation System Product Description

5.10.3 SOLAR Surgical Ablation System Clinical Trial

5.11 Cardiovascular Surgery Future Outlook

6 Cardiovascular Surgery Pipeline Product Summary

7 Cardiovascular Surgery Clinical Trial Summary

8 Appendix

8.1 Research Methodology

8.2 Coverage

8.3 Secondary Research

8.4 Primary Research

8.5 Models

8.6 Forecasts

8.7 Expert Panels

8.8 GlobalData Consulting

8.9 Contact Us

8.10 Disclaimer

1.1 List of Tables

Table 1: Cardiovascular Surgery, US, Revenue ($ m) By Category, 2001 - 2015

Table 2: CABG and Beating Heart Surgery Procedures, US, 2001 - 2015

Table 3: PEARL 8.0 Product Status

Table 4: Peral 8.0 Product Description

Table 5: Bard Pulsed RF Ablation System Product Status

Table 6: Bard Pulsed RF Ablation System Product Description

Table 7: Bard Pulsed RF Ablation System Clinical Trial

Table 8: Periocardiocentesis Tray Product Status

Table 9: Periocardiocentesis Tray Product Description

Table 10: GTU X- GRAFT Product Status

Table 11: GTU X- GRAFT Product Description

Table 12: GTU X2 - GRAFT Product Status

Table 13: GTU X2 - GRAFT Product Description

Table 14: High Intensity Focused Ultra Sound Ablation System Product Status

Table 15: High Intensity Focused Ultra Sound Ablation System Product Description

Table 16: High Intensity Focused Ultra Sound Ablation System Clinical Trial 1

Table 17: High Intensity Focused Ultra Sound Ablation System Clinical Trial 2

Table 18: HIFU (High Intensity Focused Ultrasound) Cardiac Ablation system Product Status

Table 19: HIFU (High Intensity Focused Ultrasound) Cardiac Ablation system Product Description

Table 20: Repel - CV (Child) Product Status

Table 21: Repel - CV (Child) Product Status

Table 22: Repel - CV (Child) Clinical Trial 1

Table 23: Repel - CV (Child) Clinical Trial 2

Table 24: Non - Invasive Radiosurgical System Product Status Product Status

Table 25: Non - Invasive Radiosurgical System Product Description

Table 26: ExoSeal Vascular Closure Device Product Status

Table 27: SOLAR Surgical Ablation System Product Description

Table 28: SOLAR Surgical Ablation System Clinical Trial

Table 29: Cardiovascular Surgery Devices, Pipeline Product Summary

Table 30: Cardiovascular Surgery, Clinical Trial Summary

1.2 List of Figures

Figure 1: Cardiovascular Surgery, US, Revenue ($ m) By Category, 2001 - 2015

Figure 2: CABG and Beating Heart Surgery Procedures, US, 2001 - 2015

Figure 3: Cardiovascular Surgery Cross Segment Analysis, 2008

Figure 4: Cardiovascular Surgery, Company Share (%), Global, 2008

Abstract

• Annualized global cardiovascular surgery market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
• Analysis and review of the key events and milestones that will impact the future of the global cardiovascular surgery market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
• Insightful review of key industry drivers, restraints and challenges which are likely to impact the global cardiovascular surgery market in the long run.
• In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

• Develop business strategies by understanding the trends shaping and driving the global cardiovascular surgery market.
• Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
• Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global cardiovascular surgery market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
• Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.